Global In-vivo Contract Research Organization Market

In-vivo Contract Research Organization Comprehensive Study by Services (Clinical Trials, Research Support), Therapeutic Areas (Autoimmune, Pain Management, Oncology, Nephrology, Diabetes, Cardiovascular, Orthopaedics, Others), End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes, Others), Animal Type (Rodent, -Mice, -Rat, -Hamsters, -Guinea pigs, -Gerbils, -Others, Non-rodent, -Rabbit, -Dog, -Minipigs, -Nonhuman Primates (NHPs)) Players and Region - Global Market Outlook to 2027

In-vivo Contract Research Organization Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is In-vivo Contract Research Organization Market Scope?
The institutes doing biopharmaceutical research on a contractual basis are known as in-vivo contract research organisations (CROs). In-vivo CROs are becoming more and more common as small molecule medications are increasingly being replaced by biologics. Rise in research and development activities to commercialize the generic molecule, growing number of therapies, and outsourcing of toxicology and pharmacokinetic investigations in preclinical studies are the drivers of the market. High clinical trial costs, higher concern regarding CRO quality, easy product-associated contamination, shortage of skilled personnel, and availability of suitable animals for certain testing are some of the challenges faced by the market. Due to the large patient population, developing economy, and expanding health care sector, Asia Pacific is anticipated to experience strong growth in the in-vivo CRO market.

In-vivo Contract Research Organization Market Dynamics:
AttributesDetails
Growth Drivers
  • Rise In Research and Development Activities to Commercialize the Generic Molecule
  • Growing Number of Therapies
  • Outsourcing of Toxicology and Pharmacokinetic Investigations in Preclinical Studies
Influencing Trends
  • Increased Industry Investment into Biosimilar
  • Rising Demand of Collaborations and Agreements to leverage innovation from one another in order to advance biosimilar drug development
  • Growing Need for Safety Assessment and Toxicology Services
Restraints
  • Stringent Regulatory across the regions
Road Blocks / Challenges
  • High Clinical Trial Costs
  • Higher Concern regarding CRO quality
  • Easy Product-Associated Contamination
  • Shortage of Skilled Personnel
  • Availability of Suitable Animals for Certain Testing
Gaps & Opportunities
  • Pharma MNCs are highly inclined towards Collaboration with CROs for their Product Pipeline Increase in the Number of Elderly People
  • Rising Growth of Specific Therapies in the Oncology Pipeline


The In-vivo Contract Research Organization market study is being classified, by Application and major geographies with country level break-up.

In-vivo Contract Research Organization is a consolidated market as top 5 player’s accounts for nearly 50% of industry revenue. The players are focusing on investing more in research and development activities. These will enhance their market presence. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global In-vivo Contract Research Organization market throughout the predicted period.

PPD Inc. (United States), Quintiles (United States), ICON Plc (Ireland), Parexel International Corporation (United States), American Preclinical Services, LLC (United States), Labcorp Drug Development (United States), Theorem Clinical research (United States), WuXi AppTec (China), Syneos Health (United States), Evotec (Germany), Charles River Laboratories (United States) and Liveon Biolabs Pvt.Ltd. (India) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global In-vivo Contract Research Organization market by Type, Application and Region.

On the basis of geography, the market of In-vivo Contract Research Organization has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In October 2021, Plato BioPharma, Inc. ("PBI"), a Colorado-based in vivo pharmacology research and drug discovery company specialising in cardiovascular, renal, pulmonary, and hepatic therapeutic areas, had been acquired by Inotiv, Inc., a leading contract research organisation, specialising in nonclinical and analytical drug discovery and development services, for a price of USD 15 million. This acquisition will help Inotiv's expanding discovery operations in Boulder, Colorado, since PBI is actively expanding its facility capacity to accommodate roughly twice as much business as it already does to meet the rising demand for services.
In February 2022, THREAD, leading technology and global provider enabling electronic clinical outcome assessments (eCOAs) and decentralised clinical trials (DCTs), and EVERSANA, the pioneer of next-generation commercial services to the global life sciences industry, announced a new combined offering to give pharmaceutical companies a comprehensive and simultaneous view of clinical research participants, followed by data and detailed analysis across the care continuum. and In February 2020, the life sciences company IQVIA is a prominent global provider of advanced analytics, technological solutions, and contract research services, announced the introduction of Avacare Clinical Research NetworkTM, a technology-based global site network that expands clinical trial possibilities at established clinical and research sites. Avacare's exclusive analytical technologies assist sites in the Avacare network in better matching patients to clinical trials.
A contract research organisation (CRO), specifically in relation to clinical trials services, is defined by the International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, a 2015 Swiss NGO of pharmaceutical corporations and others, as: "A person or an organisation (commercial, academic, or other) contracted by the sponsor to undertake one or more of a sponsor's trial-related obligations and functions”., It further details the sponsor's responsibilities in its good clinical practice guidelines: and • A sponsor may delegate any or all of their trial-related responsibilities to a CRO, but the sponsor will always be ultimately responsible for the accuracy and integrity of the trial data. Quality assurance and quality control should be implemented by the CRO.

Key Target Audience
Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Academic Institutes, Regulatory Bodies, Clinical Research Organizations, Research Institutes and End Users

In-vivo Contract Research Organization Market Study: Important Years
AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period-2027
Historical Period2017-2021
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Services
  • Clinical Trials
  • Research Support

By Therapeutic Areas
  • Autoimmune
  • Pain Management
  • Oncology
  • Nephrology
  • Diabetes
  • Cardiovascular
  • Orthopaedics
  • Others

By End-User
  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Academic Institutes
  • Others

By Animal Type
  • Rodent
  • -Mice
  • -Rat
  • -Hamsters
  • -Guinea pigs
  • -Gerbils
  • -Others
  • Non-rodent
  • -Rabbit
  • -Dog
  • -Minipigs
  • -Nonhuman Primates (NHPs)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise In Research and Development Activities to Commercialize the Generic Molecule
      • 3.2.2. Growing Number of Therapies
      • 3.2.3. Outsourcing of Toxicology and Pharmacokinetic Investigations in Preclinical Studies
    • 3.3. Market Challenges
      • 3.3.1. High Clinical Trial Costs
      • 3.3.2. Higher Concern regarding CRO quality
      • 3.3.3. Easy Product-Associated Contamination
      • 3.3.4. Shortage of Skilled Personnel
      • 3.3.5. Availability of Suitable Animals for Certain Testing
    • 3.4. Market Trends
      • 3.4.1. Increased Industry Investment into Biosimilar
      • 3.4.2. Rising Demand of Collaborations and Agreements to leverage innovation from one another in order to advance biosimilar drug development
      • 3.4.3. Growing Need for Safety Assessment and Toxicology Services
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global In-vivo Contract Research Organization, by Services, Therapeutic Areas, End-User, Animal Type and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global In-vivo Contract Research Organization (Value)
      • 5.2.1. Global In-vivo Contract Research Organization by: Services (Value)
        • 5.2.1.1. Clinical Trials
        • 5.2.1.2. Research Support
      • 5.2.2. Global In-vivo Contract Research Organization by: Therapeutic Areas (Value)
        • 5.2.2.1. Autoimmune
        • 5.2.2.2. Pain Management
        • 5.2.2.3. Oncology
        • 5.2.2.4. Nephrology
        • 5.2.2.5. Diabetes
        • 5.2.2.6. Cardiovascular
        • 5.2.2.7. Orthopaedics
        • 5.2.2.8. Others
      • 5.2.3. Global In-vivo Contract Research Organization by: End-User (Value)
        • 5.2.3.1. Pharmaceutical & Biopharmaceutical Companies
        • 5.2.3.2. Medical Device Companies
        • 5.2.3.3. Academic Institutes
        • 5.2.3.4. Others
      • 5.2.4. Global In-vivo Contract Research Organization by: Animal Type (Value)
        • 5.2.4.1. Rodent
        • 5.2.4.2. -Mice
        • 5.2.4.3. -Rat
        • 5.2.4.4. -Hamsters
        • 5.2.4.5. -Guinea pigs
        • 5.2.4.6. -Gerbils
        • 5.2.4.7. -Others
        • 5.2.4.8. Non-rodent
        • 5.2.4.9. -Rabbit
        • 5.2.4.10. -Dog
        • 5.2.4.11. -Minipigs
        • 5.2.4.12. -Nonhuman Primates (NHPs)
      • 5.2.5. Global In-vivo Contract Research Organization Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global In-vivo Contract Research Organization (Price)
  • 6. In-vivo Contract Research Organization: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. PPD Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Quintiles (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ICON Plc (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Parexel International Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. American Preclinical Services, LLC (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Labcorp Drug Development (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Theorem Clinical research (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. WuXi AppTec (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Syneos Health (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Evotec (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Charles River Laboratories (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Liveon Biolabs Pvt.Ltd. (India)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global In-vivo Contract Research Organization Sale, by Services, Therapeutic Areas, End-User, Animal Type and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global In-vivo Contract Research Organization (Value)
      • 7.2.1. Global In-vivo Contract Research Organization by: Services (Value)
        • 7.2.1.1. Clinical Trials
        • 7.2.1.2. Research Support
      • 7.2.2. Global In-vivo Contract Research Organization by: Therapeutic Areas (Value)
        • 7.2.2.1. Autoimmune
        • 7.2.2.2. Pain Management
        • 7.2.2.3. Oncology
        • 7.2.2.4. Nephrology
        • 7.2.2.5. Diabetes
        • 7.2.2.6. Cardiovascular
        • 7.2.2.7. Orthopaedics
        • 7.2.2.8. Others
      • 7.2.3. Global In-vivo Contract Research Organization by: End-User (Value)
        • 7.2.3.1. Pharmaceutical & Biopharmaceutical Companies
        • 7.2.3.2. Medical Device Companies
        • 7.2.3.3. Academic Institutes
        • 7.2.3.4. Others
      • 7.2.4. Global In-vivo Contract Research Organization by: Animal Type (Value)
        • 7.2.4.1. Rodent
        • 7.2.4.2. -Mice
        • 7.2.4.3. -Rat
        • 7.2.4.4. -Hamsters
        • 7.2.4.5. -Guinea pigs
        • 7.2.4.6. -Gerbils
        • 7.2.4.7. -Others
        • 7.2.4.8. Non-rodent
        • 7.2.4.9. -Rabbit
        • 7.2.4.10. -Dog
        • 7.2.4.11. -Minipigs
        • 7.2.4.12. -Nonhuman Primates (NHPs)
      • 7.2.5. Global In-vivo Contract Research Organization Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global In-vivo Contract Research Organization (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. In-vivo Contract Research Organization: by Services(USD Million)
  • Table 2. In-vivo Contract Research Organization Clinical Trials , by Region USD Million (2016-2021)
  • Table 3. In-vivo Contract Research Organization Research Support , by Region USD Million (2016-2021)
  • Table 4. In-vivo Contract Research Organization: by Therapeutic Areas(USD Million)
  • Table 5. In-vivo Contract Research Organization Autoimmune , by Region USD Million (2016-2021)
  • Table 6. In-vivo Contract Research Organization Pain Management , by Region USD Million (2016-2021)
  • Table 7. In-vivo Contract Research Organization Oncology , by Region USD Million (2016-2021)
  • Table 8. In-vivo Contract Research Organization Nephrology , by Region USD Million (2016-2021)
  • Table 9. In-vivo Contract Research Organization Diabetes , by Region USD Million (2016-2021)
  • Table 10. In-vivo Contract Research Organization Cardiovascular , by Region USD Million (2016-2021)
  • Table 11. In-vivo Contract Research Organization Orthopaedics , by Region USD Million (2016-2021)
  • Table 12. In-vivo Contract Research Organization Others , by Region USD Million (2016-2021)
  • Table 13. In-vivo Contract Research Organization: by End-User(USD Million)
  • Table 14. In-vivo Contract Research Organization Pharmaceutical & Biopharmaceutical Companies , by Region USD Million (2016-2021)
  • Table 15. In-vivo Contract Research Organization Medical Device Companies , by Region USD Million (2016-2021)
  • Table 16. In-vivo Contract Research Organization Academic Institutes , by Region USD Million (2016-2021)
  • Table 17. In-vivo Contract Research Organization Others , by Region USD Million (2016-2021)
  • Table 18. In-vivo Contract Research Organization: by Animal Type(USD Million)
  • Table 19. In-vivo Contract Research Organization Rodent , by Region USD Million (2016-2021)
  • Table 20. In-vivo Contract Research Organization -Mice , by Region USD Million (2016-2021)
  • Table 21. In-vivo Contract Research Organization -Rat , by Region USD Million (2016-2021)
  • Table 22. In-vivo Contract Research Organization -Hamsters , by Region USD Million (2016-2021)
  • Table 23. In-vivo Contract Research Organization -Guinea pigs , by Region USD Million (2016-2021)
  • Table 24. In-vivo Contract Research Organization -Gerbils , by Region USD Million (2016-2021)
  • Table 25. In-vivo Contract Research Organization -Others , by Region USD Million (2016-2021)
  • Table 26. In-vivo Contract Research Organization Non-rodent , by Region USD Million (2016-2021)
  • Table 27. In-vivo Contract Research Organization -Rabbit , by Region USD Million (2016-2021)
  • Table 28. In-vivo Contract Research Organization -Dog , by Region USD Million (2016-2021)
  • Table 29. In-vivo Contract Research Organization -Minipigs , by Region USD Million (2016-2021)
  • Table 30. In-vivo Contract Research Organization -Nonhuman Primates (NHPs) , by Region USD Million (2016-2021)
  • Table 31. South America In-vivo Contract Research Organization, by Country USD Million (2016-2021)
  • Table 32. South America In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 33. South America In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 34. South America In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 35. South America In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 36. Brazil In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 37. Brazil In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 38. Brazil In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 39. Brazil In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 40. Argentina In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 41. Argentina In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 42. Argentina In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 43. Argentina In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 44. Rest of South America In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 45. Rest of South America In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 46. Rest of South America In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 47. Rest of South America In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 48. Asia Pacific In-vivo Contract Research Organization, by Country USD Million (2016-2021)
  • Table 49. Asia Pacific In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 50. Asia Pacific In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 51. Asia Pacific In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 52. Asia Pacific In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 53. China In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 54. China In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 55. China In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 56. China In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 57. Japan In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 58. Japan In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 59. Japan In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 60. Japan In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 61. India In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 62. India In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 63. India In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 64. India In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 65. South Korea In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 66. South Korea In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 67. South Korea In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 68. South Korea In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 69. Taiwan In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 70. Taiwan In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 71. Taiwan In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 72. Taiwan In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 73. Australia In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 74. Australia In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 75. Australia In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 76. Australia In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 77. Rest of Asia-Pacific In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 78. Rest of Asia-Pacific In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 79. Rest of Asia-Pacific In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 80. Rest of Asia-Pacific In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 81. Europe In-vivo Contract Research Organization, by Country USD Million (2016-2021)
  • Table 82. Europe In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 83. Europe In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 84. Europe In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 85. Europe In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 86. Germany In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 87. Germany In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 88. Germany In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 89. Germany In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 90. France In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 91. France In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 92. France In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 93. France In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 94. Italy In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 95. Italy In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 96. Italy In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 97. Italy In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 98. United Kingdom In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 99. United Kingdom In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 100. United Kingdom In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 101. United Kingdom In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 102. Netherlands In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 103. Netherlands In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 104. Netherlands In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 105. Netherlands In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 106. Rest of Europe In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 107. Rest of Europe In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 108. Rest of Europe In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 109. Rest of Europe In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 110. MEA In-vivo Contract Research Organization, by Country USD Million (2016-2021)
  • Table 111. MEA In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 112. MEA In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 113. MEA In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 114. MEA In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 115. Middle East In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 116. Middle East In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 117. Middle East In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 118. Middle East In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 119. Africa In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 120. Africa In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 121. Africa In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 122. Africa In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 123. North America In-vivo Contract Research Organization, by Country USD Million (2016-2021)
  • Table 124. North America In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 125. North America In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 126. North America In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 127. North America In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 128. United States In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 129. United States In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 130. United States In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 131. United States In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 132. Canada In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 133. Canada In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 134. Canada In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 135. Canada In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 136. Mexico In-vivo Contract Research Organization, by Services USD Million (2016-2021)
  • Table 137. Mexico In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2016-2021)
  • Table 138. Mexico In-vivo Contract Research Organization, by End-User USD Million (2016-2021)
  • Table 139. Mexico In-vivo Contract Research Organization, by Animal Type USD Million (2016-2021)
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Company Basic Information, Sales Area and Its Competitors
  • Table 150. Company Basic Information, Sales Area and Its Competitors
  • Table 151. Company Basic Information, Sales Area and Its Competitors
  • Table 152. In-vivo Contract Research Organization: by Services(USD Million)
  • Table 153. In-vivo Contract Research Organization Clinical Trials , by Region USD Million (2022-2027)
  • Table 154. In-vivo Contract Research Organization Research Support , by Region USD Million (2022-2027)
  • Table 155. In-vivo Contract Research Organization: by Therapeutic Areas(USD Million)
  • Table 156. In-vivo Contract Research Organization Autoimmune , by Region USD Million (2022-2027)
  • Table 157. In-vivo Contract Research Organization Pain Management , by Region USD Million (2022-2027)
  • Table 158. In-vivo Contract Research Organization Oncology , by Region USD Million (2022-2027)
  • Table 159. In-vivo Contract Research Organization Nephrology , by Region USD Million (2022-2027)
  • Table 160. In-vivo Contract Research Organization Diabetes , by Region USD Million (2022-2027)
  • Table 161. In-vivo Contract Research Organization Cardiovascular , by Region USD Million (2022-2027)
  • Table 162. In-vivo Contract Research Organization Orthopaedics , by Region USD Million (2022-2027)
  • Table 163. In-vivo Contract Research Organization Others , by Region USD Million (2022-2027)
  • Table 164. In-vivo Contract Research Organization: by End-User(USD Million)
  • Table 165. In-vivo Contract Research Organization Pharmaceutical & Biopharmaceutical Companies , by Region USD Million (2022-2027)
  • Table 166. In-vivo Contract Research Organization Medical Device Companies , by Region USD Million (2022-2027)
  • Table 167. In-vivo Contract Research Organization Academic Institutes , by Region USD Million (2022-2027)
  • Table 168. In-vivo Contract Research Organization Others , by Region USD Million (2022-2027)
  • Table 169. In-vivo Contract Research Organization: by Animal Type(USD Million)
  • Table 170. In-vivo Contract Research Organization Rodent , by Region USD Million (2022-2027)
  • Table 171. In-vivo Contract Research Organization -Mice , by Region USD Million (2022-2027)
  • Table 172. In-vivo Contract Research Organization -Rat , by Region USD Million (2022-2027)
  • Table 173. In-vivo Contract Research Organization -Hamsters , by Region USD Million (2022-2027)
  • Table 174. In-vivo Contract Research Organization -Guinea pigs , by Region USD Million (2022-2027)
  • Table 175. In-vivo Contract Research Organization -Gerbils , by Region USD Million (2022-2027)
  • Table 176. In-vivo Contract Research Organization -Others , by Region USD Million (2022-2027)
  • Table 177. In-vivo Contract Research Organization Non-rodent , by Region USD Million (2022-2027)
  • Table 178. In-vivo Contract Research Organization -Rabbit , by Region USD Million (2022-2027)
  • Table 179. In-vivo Contract Research Organization -Dog , by Region USD Million (2022-2027)
  • Table 180. In-vivo Contract Research Organization -Minipigs , by Region USD Million (2022-2027)
  • Table 181. In-vivo Contract Research Organization -Nonhuman Primates (NHPs) , by Region USD Million (2022-2027)
  • Table 182. South America In-vivo Contract Research Organization, by Country USD Million (2022-2027)
  • Table 183. South America In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 184. South America In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 185. South America In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 186. South America In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 187. Brazil In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 188. Brazil In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 189. Brazil In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 190. Brazil In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 191. Argentina In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 192. Argentina In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 193. Argentina In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 194. Argentina In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 195. Rest of South America In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 196. Rest of South America In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 197. Rest of South America In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 198. Rest of South America In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 199. Asia Pacific In-vivo Contract Research Organization, by Country USD Million (2022-2027)
  • Table 200. Asia Pacific In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 201. Asia Pacific In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 202. Asia Pacific In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 203. Asia Pacific In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 204. China In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 205. China In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 206. China In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 207. China In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 208. Japan In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 209. Japan In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 210. Japan In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 211. Japan In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 212. India In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 213. India In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 214. India In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 215. India In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 216. South Korea In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 217. South Korea In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 218. South Korea In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 219. South Korea In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 220. Taiwan In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 221. Taiwan In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 222. Taiwan In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 223. Taiwan In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 224. Australia In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 225. Australia In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 226. Australia In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 227. Australia In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 228. Rest of Asia-Pacific In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 229. Rest of Asia-Pacific In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 230. Rest of Asia-Pacific In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 231. Rest of Asia-Pacific In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 232. Europe In-vivo Contract Research Organization, by Country USD Million (2022-2027)
  • Table 233. Europe In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 234. Europe In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 235. Europe In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 236. Europe In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 237. Germany In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 238. Germany In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 239. Germany In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 240. Germany In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 241. France In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 242. France In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 243. France In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 244. France In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 245. Italy In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 246. Italy In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 247. Italy In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 248. Italy In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 249. United Kingdom In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 250. United Kingdom In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 251. United Kingdom In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 252. United Kingdom In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 253. Netherlands In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 254. Netherlands In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 255. Netherlands In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 256. Netherlands In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 257. Rest of Europe In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 258. Rest of Europe In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 259. Rest of Europe In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 260. Rest of Europe In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 261. MEA In-vivo Contract Research Organization, by Country USD Million (2022-2027)
  • Table 262. MEA In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 263. MEA In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 264. MEA In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 265. MEA In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 266. Middle East In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 267. Middle East In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 268. Middle East In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 269. Middle East In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 270. Africa In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 271. Africa In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 272. Africa In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 273. Africa In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 274. North America In-vivo Contract Research Organization, by Country USD Million (2022-2027)
  • Table 275. North America In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 276. North America In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 277. North America In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 278. North America In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 279. United States In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 280. United States In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 281. United States In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 282. United States In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 283. Canada In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 284. Canada In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 285. Canada In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 286. Canada In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 287. Mexico In-vivo Contract Research Organization, by Services USD Million (2022-2027)
  • Table 288. Mexico In-vivo Contract Research Organization, by Therapeutic Areas USD Million (2022-2027)
  • Table 289. Mexico In-vivo Contract Research Organization, by End-User USD Million (2022-2027)
  • Table 290. Mexico In-vivo Contract Research Organization, by Animal Type USD Million (2022-2027)
  • Table 291. Research Programs/Design for This Report
  • Table 292. Key Data Information from Secondary Sources
  • Table 293. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global In-vivo Contract Research Organization: by Services USD Million (2016-2021)
  • Figure 5. Global In-vivo Contract Research Organization: by Therapeutic Areas USD Million (2016-2021)
  • Figure 6. Global In-vivo Contract Research Organization: by End-User USD Million (2016-2021)
  • Figure 7. Global In-vivo Contract Research Organization: by Animal Type USD Million (2016-2021)
  • Figure 8. South America In-vivo Contract Research Organization Share (%), by Country
  • Figure 9. Asia Pacific In-vivo Contract Research Organization Share (%), by Country
  • Figure 10. Europe In-vivo Contract Research Organization Share (%), by Country
  • Figure 11. MEA In-vivo Contract Research Organization Share (%), by Country
  • Figure 12. North America In-vivo Contract Research Organization Share (%), by Country
  • Figure 13. Global In-vivo Contract Research Organization share by Players 2021 (%)
  • Figure 14. Global In-vivo Contract Research Organization share by Players (Top 3) 2021(%)
  • Figure 15. Global In-vivo Contract Research Organization share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. PPD Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. PPD Inc. (United States) Revenue: by Geography 2021
  • Figure 19. Quintiles (United States) Revenue, Net Income and Gross profit
  • Figure 20. Quintiles (United States) Revenue: by Geography 2021
  • Figure 21. ICON Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 22. ICON Plc (Ireland) Revenue: by Geography 2021
  • Figure 23. Parexel International Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Parexel International Corporation (United States) Revenue: by Geography 2021
  • Figure 25. American Preclinical Services, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 26. American Preclinical Services, LLC (United States) Revenue: by Geography 2021
  • Figure 27. Labcorp Drug Development (United States) Revenue, Net Income and Gross profit
  • Figure 28. Labcorp Drug Development (United States) Revenue: by Geography 2021
  • Figure 29. Theorem Clinical research (United States) Revenue, Net Income and Gross profit
  • Figure 30. Theorem Clinical research (United States) Revenue: by Geography 2021
  • Figure 31. WuXi AppTec (China) Revenue, Net Income and Gross profit
  • Figure 32. WuXi AppTec (China) Revenue: by Geography 2021
  • Figure 33. Syneos Health (United States) Revenue, Net Income and Gross profit
  • Figure 34. Syneos Health (United States) Revenue: by Geography 2021
  • Figure 35. Evotec (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Evotec (Germany) Revenue: by Geography 2021
  • Figure 37. Charles River Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 38. Charles River Laboratories (United States) Revenue: by Geography 2021
  • Figure 39. Liveon Biolabs Pvt.Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 40. Liveon Biolabs Pvt.Ltd. (India) Revenue: by Geography 2021
  • Figure 41. Global In-vivo Contract Research Organization: by Services USD Million (2022-2027)
  • Figure 42. Global In-vivo Contract Research Organization: by Therapeutic Areas USD Million (2022-2027)
  • Figure 43. Global In-vivo Contract Research Organization: by End-User USD Million (2022-2027)
  • Figure 44. Global In-vivo Contract Research Organization: by Animal Type USD Million (2022-2027)
  • Figure 45. South America In-vivo Contract Research Organization Share (%), by Country
  • Figure 46. Asia Pacific In-vivo Contract Research Organization Share (%), by Country
  • Figure 47. Europe In-vivo Contract Research Organization Share (%), by Country
  • Figure 48. MEA In-vivo Contract Research Organization Share (%), by Country
  • Figure 49. North America In-vivo Contract Research Organization Share (%), by Country
List of companies from research coverage that are profiled in the study
  • PPD Inc. (United States)
  • Quintiles (United States)
  • ICON Plc (Ireland)
  • Parexel International Corporation (United States)
  • American Preclinical Services, LLC (United States)
  • Labcorp Drug Development (United States)
  • Theorem Clinical research (United States)
  • WuXi AppTec (China)
  • Syneos Health (United States)
  • Evotec (Germany)
  • Charles River Laboratories (United States)
  • Liveon Biolabs Pvt.Ltd. (India)
Select User Access Type

Key Highlights of Report


Jul 2022 216 Pages 77 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global In-vivo Contract Research Organization Market Quantitative research analysis
Global In-vivo Contract Research Organization Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global In-vivo Contract Research Organization market are PPD Inc. (United States), Quintiles (United States), ICON Plc (Ireland), Parexel International Corporation (United States), American Preclinical Services, LLC (United States), Labcorp Drug Development (United States), Theorem Clinical research (United States), WuXi AppTec (China), Syneos Health (United States), Evotec (Germany), Charles River Laboratories (United States) and Liveon Biolabs Pvt.Ltd. (India).
In this highly competitive & fast evolving In-vivo Contract Research Organization industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global In-vivo Contract Research Organization Market Report?

Have a Query? Click Here

Other Related Reports

Heart Transplant Comprehensive Study by Demographics (Gender, -Male, -Female, -Unisex, Age, -0-10 Years, -11-29 Years, -30-49 Years, -50-69 Years, Others), End Users (Hospitals, Cardiac Institute, Ot...
$ 3800
Systemic Psoriasis Therapeutic Comprehensive Study by Type (Plaque Psoriasis, Psoriatic Arthritis, Others), Route of Administration (Oral, Parenteral/Systemic, Topical), Distribution Channel (Direct,...
$ 3800
Systemic Lupus Erythematosus Treatment Comprehensive Study by Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Antimalarial Drugs, Corticosteroids, Immunosuppressants, Biologics, Others), End use...
$ 3800
Human Papillomavirus Therapeutics Comprehensive Study by Route of Administration (Parenteral, Topical), Vaccine Type (Peptide-based Vaccines, Protein-based Vaccines, Viral-vectored vaccines, Bacteria...
$ 3800
Neuropsychiatric Disorders And Treatment Comprehensive Study by Types (Degenerative Diseases, Psychosis, Neurotic Disorder), End Users (Hospitals, Specialty Clinics, Research & Development Centers, A...
$ 3800
Sepsis and Septic Shock Comprehensive Study by Type (Automated Diagnostics, Conventional Diagnostics), By End User (Hospitals, Pathology Center, Laboratories, Research Organization, Others), By Techn...
$ 3800